These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26593979)

  • 1. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
    Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
    Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
    Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
    Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
    Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
    J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
    Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
    Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
    FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-Mediated Interference of PB2-eIF4G1 Interaction Inhibits Influenza A Viruses' Replication in Vitro and in Vivo.
    Yuan S; Chu H; Ye J; Hu M; Singh K; Chow BK; Zhou J; Zheng BJ
    ACS Infect Dis; 2016 Jul; 2(7):471-7. PubMed ID: 27626099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
    Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
    Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.
    Wanitchang A; Jengarn J; Jongkaewwattana A
    Virus Res; 2011 Jan; 155(1):325-33. PubMed ID: 21056603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
    Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
    Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
    Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
    J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
    Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
    Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
    Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
    Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.
    Yamayoshi S; Watanabe M; Goto H; Kawaoka Y
    J Virol; 2016 Jan; 90(1):444-56. PubMed ID: 26491155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.